Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper ...

Approximately 10.5 million Americans have atrial fibrillation (AFib), a condition that causes an irregular, often too fast, ...

Boston Scientific (NYSE: BSX) announced today that its Farapulse pulsed field ablation (PFA) system received expanded CE mark ...

Abbott has secured the US Food and Drug Administration (FDA) approval for its next-generation CardioMEMS HERO device, which ...

With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.

Johnson & Johnson (NYSE: JNJ) on Friday after hours released data from the OMNY-AF pilot study, a prospective, single-arm, multi-center trial. The study pairs the OMNYPULSE Catheter, a 12 mm large-tip ...

That's a big leap over a relatively short period, and the trend offers a significant opportunity for medical device makers, ...

Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a quivering or irregular heartbeat that can lead to blood clots, stroke and heart ...

Most of the time, you don't think about your heartbeat. It works quietly in the background of your day. But sometimes your ...

Jim Kaveney launches a movement that bridges science and soul, helping people with atrial fibrillation reclaim agency, ...

Institut Jantung Negara (IJN) has achieved a significant medical milestone by becoming the first hospital in Asia to clinically utilise the Affera Prism-2 Mapping and Ablation System for the treatment ...